Nurix Product Manager Interview: Questions & Prep (2026)

Nurix AI is a clinical-stage biotech company building small-molecule drugs through AI-powered targeted protein degradation platforms. As of July 2026, knok's job radar shows 7 open Product Manager roles at Nurix. PM interviews here typically cover product strategy, cross-functional collaboration with scientists and engineers, and your ability to translate complex biology into clear product roadmaps.

Candidates report a process that usually spans a screening call, a case study or take-home exercise, and panel rounds with science, engineering, and leadership stakeholders. Nurix PMs sit at the intersection of AI and drug discovery, so interviewers look for both sharp product thinking and genuine curiosity about the domain. All process details in this guide are based on candidate reports and may vary by role.

Questions candidates report facing in Nurix PM interviews:

1. How would you define the product roadmap for an AI drug-discovery platform where most users are research scientists?
2. Nurix works at the intersection of AI and biology. How do you make product decisions when the science is uncertain and timelines are long?
3. Tell us about a time you launched a product or feature used by a highly technical audience.
4. How do you prioritise between a feature that improves researcher productivity and one that directly advances a drug candidate?
5. Describe a situation where data from an experiment contradicted your product assumptions. What did you do?
6. How would you measure the success of a new AI model integrated into Nurix's discovery workflow?
7. Walk us through how you would gather requirements from computational biologists and medicinal chemists who have very different ways of thinking.
8. You have limited engineering bandwidth and three competing teams (biology, ML, and clinical operations) each requesting features urgently. How do you decide?
9. Tell us about a product you sunset or deprioritised. How did you handle pushback from stakeholders?
10. How do you stay current on AI and ML developments and evaluate which ones are worth building into a scientific platform?
11. Nurix's drugs go through years of development before any market signal. How do you keep your team motivated and measure progress without traditional product metrics?
12. If you joined Nurix tomorrow, what would be your top priorities in your first few weeks on the job?

Q: Tell us about a time you launched a product or feature used by a highly technical audience.

*Situation:* I was PM for an internal data annotation tool at a healthtech company, used daily by ML engineers and domain experts.

*Task:* The existing tool was a generic labelling platform that did not support the structured ontologies our scientists needed. Adoption was low and data quality was inconsistent across teams.

*Action:* I ran contextual interviews with scientists and ML engineers to understand their annotation workflows in detail. I worked with engineering to add domain-specific label hierarchies, keyboard shortcuts for power users, and a QA review layer. I kept scientists in the loop with weekly demos rather than waiting for a big launch.

*Result:* Adoption improved significantly within a quarter of launch, and the ML team reported fewer data quality issues in downstream model training.

---

Q: How do you prioritise between competing requests from different scientific teams?

*Situation:* At a bioinformatics SaaS company, I managed a platform used by both wet-lab and computational biology teams.

*Task:* Both teams submitted feature requests for the same sprint. Wet-lab wanted better experiment tracking. Comp bio wanted faster data export APIs. I had engineering capacity for only one.

*Action:* I built a simple scoring matrix using impact on core workflows, users affected, and dependency on upcoming milestones. I also spoke directly to team leads to understand urgency and available workarounds. The analysis showed the export API was blocking a critical ML pipeline that was already delaying a key deliverable.

*Result:* I shipped the API first, unblocked the ML team, and negotiated a clear timeline for experiment tracking in the next sprint. Both teams felt heard and the decision was fully transparent.

---

Q: Describe a time you made a product decision with incomplete data.

*Situation:* I was building a new search feature for a research document management system. We had limited user research responses and no prior usage analytics to guide the direction.

*Task:* I had to decide between building keyword-based search first or jumping straight to semantic search powered by embeddings. The team had strong opinions on both sides.

*Action:* I framed the decision around risk and reversibility. Keyword search was faster to ship and could validate whether search was even a top pain point. I proposed shipping keyword search with clear instrumentation so we could measure query patterns before committing to the more complex semantic approach.

*Result:* The instrumentation revealed that most users searched by author name and date, not by content. This changed our entire next sprint and we avoided building a semantic search system that would have solved the wrong problem.

Several frameworks come up repeatedly in PM interviews, especially at data-and-science-heavy companies like Nurix.

STAR for behavioural questions: Situation, Task, Action, Result. Keep your Result concrete even if you cannot share exact figures. 'Adoption improved significantly' is more credible than a vague statement with no context.

CIRCLES for product design questions: Comprehend the situation, Identify the customer, Report customer needs, Cut through prioritisation, List solutions, Evaluate trade-offs, Summarise. Useful when asked to 'design a product for X'.

North Star Metric plus Input Metrics: Define one metric that best represents value delivered (the North Star), then break it into leading indicators your team can actually influence. For a drug-discovery platform, the North Star might be 'successful experiments per researcher per quarter' since traditional activation and retention metrics do not fit research workflows well.

Impact vs Effort matrix for prioritisation: Plot features on a two-by-two grid of impact (high/low) and effort (high/low). In a Nurix context, consider replacing 'effort' with 'scientific uncertainty' or 'regulatory risk' to make the framework relevant to their domain.

PRD structure for take-home rounds: Problem statement, success metrics, user stories, scope (in/out), risks, open questions. Candidates report that Nurix sometimes includes a short product case study as part of the interview process.

Interviewers at biotech-AI companies typically look for several things beyond standard PM skills.

Science literacy without being a scientist: You do not need a PhD, but you need to show genuine curiosity about how their technology works and the ability to ask sharp questions. Candidates who cannot explain protein degradation at a high level tend to struggle building credibility with Nurix's research teams.

Comfort with long feedback loops: Most drug-discovery products do not show results for months or years. Interviewers want to see that you can define meaningful leading indicators and keep teams focused when the end outcome is far away.

Cross-functional empathy: Nurix teams mix computational scientists, chemists, clinicians, and engineers. Show that you have worked effectively across disciplines where people have fundamentally different mental models and vocabularies.

Data-driven but uncertainty-tolerant: Strong candidates talk about decisions they made with limited or ambiguous data. They show structured thinking without pretending to have certainty they do not have.

Mission alignment: Nurix is building medicines for patients with serious diseases. Interviewers notice when candidates connect product decisions to patient outcomes, not just business metrics.

Understand the company and domain first

Read Nurix's published pipeline and investor materials to understand their core technology (targeted protein degradation and E3 ligase biology). You do not need to become an expert, but knowing what targeted degradation means and why it matters positions you well. Look up recent coverage in industry publications to understand their current clinical stage and therapeutic focus areas.

Prepare your stories

Map your past experience to the questions most likely to come up. You need at least one strong story each for: leading a technical audience, prioritising under constraints, dealing with ambiguous data, and influencing without authority. Practice delivering them in STAR format out loud, not just in notes.

Practice case studies

Candidates report that Nurix and similar biotech-AI companies typically include a product case or take-home exercise. Practice writing a product brief for a scientific tool: start with user research, define metrics relevant to research workflows, and justify your trade-offs explicitly. Keep your scope realistic and your assumptions visible.

Prepare smart questions for each round

Prepare a few thoughtful questions for each interviewer based on their role. Asking a computational scientist about their biggest workflow pain point signals far more curiosity than generic questions about company culture.

Once your preparation is solid, finding the right roles should not slow you down. knok checks 150+ job sites nightly, applies to roles matching your resume, and messages HR for you so you can keep your focus on interview preparation.

Applying consumer-product frameworks without adaptation: Saying 'I would measure DAU and retention' for a drug-discovery platform signals you have not thought about the domain. Adapt standard frameworks to research workflows and explain why.

Over-claiming scientific expertise: If you do not have a biology background, do not pretend to. Interviewers at companies like Nurix respect candidates who are direct about their knowledge gaps and curious about learning.

Generic answers to prioritisation questions: 'I align with stakeholders and use data' is too vague. Show the specific process: who you spoke to, what criteria you used, and how you documented and communicated the decision.

Ignoring mission in your answers: Nurix is a clinical-stage company. Answers that treat their internal tools purely as a business problem, with no connection to research outcomes or patients, tend to land flat with interviewers.

Underselling your impact because you cannot share numbers: If you are under NDA, say so and describe relative impact instead. 'Adoption went from low to strong within a quarter' is credible. Silence on results looks like there were none.

Not asking questions: Candidates report that interviews at science-focused companies place real value on curiosity. Coming with no questions, or only asking about compensation, signals low engagement with the work.